Speculative, but we need more pharma companies to make immunotherapy drugs.
Stock price when the opinion was issued
As of Nov 02, 2026. Market Open.
He likes their model, and there is no demand for their products.
Build your watch list
Sign in to track investmentsyou care about
ETF Capital Management Inc.
Rule Investment Media
Stockchase
CNBC
Raymond James
Speculative, but we need more pharma companies to make immunotherapy drugs.